J.david Renzelmann

EvidentIQ is a next generation technology-amplified data science group championing new standards in value creation and innovation driven relevance for customers. The EvidentIQ offering brings a pioneering end-to-end eClinical solution that meets increasing customer demand across clinical operations and clinical data management needs with a suite of applications within a single integrated cloud platform. By combining its platform with a broad data science service portfolio such as patient recruitment, patient engagement media and a host of RWE late phase solutions EvidentIQ significantly helps customers optimize HTA submissions, pricing and reimbursement needs. EvidentIQ supports 15 of the top 20 pharma companies through novel RWE solutions and 150+ SMB customers in over 20 countries, including US, Germany, France, UK, Italy, Japan and China. -------------------------------- MORE ABOUT US: End-to-end eClinical Solution > Meeting increasing customerdemand across clinical operations and clinical data management needs with a suite of applications within a single integrated cloud platform, including EDC, CTMS, eTMF, eCOA, coding, remote monitoring, RBM, RTSM, Payments and eFeasibility. Patient Access > A digital CRO with a direct access to 500,000+ patients and caregivers allowing quick turnaround and cost- efficient patient recruitment and engagement. No doctor/ investigator/ patient advocacy groups bias in data collection. Geographical Reach > In-country patient communities platform in North America and Western Europe (EU5) and ability to conduct studies at a broader scale (LatAM, Asia...). Fast, flexible and focused services ranging from ‘full service’ to ‘do-it-yourself’. Select the services you require and create the ideal mix of professional study setup, consulting and training services to meet your specific needs. Data Science > Proprietary tools specifically designed to support our projects. In-house team able to quickly develop, adapt, and monitor.